J. Larsson et al., Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice, EMBO J, 20(7), 2001, pp. 1663-1673
Deletion of the transforming growth factor beta1 (TGF-beta1) gene in mice h
as previously suggested that it regulates both hematopoiesis and angiogenes
is. To define the function of TGF-beta more precisely, we inactivated the T
GF-beta type I receptor (T beta RI) gene by gene targeting. Mice lacking T
beta RI die at midgestation, exhibiting severe defects in vascular developm
ent of the yolk sac and placenta, and an absence of circulating red blood c
ells. However, despite obvious anemia in the T beta RI-/- yolk sacs, clonog
enic assays on yolk sac-derived hematopoietic precursors in vitro revealed
that T beta RI-/- mice exhibit normal hematopoietic potential compared with
wild-type and heterozygous siblings, Endothelial cells derived from T beta
RI-deficient embryos show enhanced cell proliferation, improper migratory
behavior and impaired fibronectin production in vitro, defects that are ass
ociated with the vascular defects seen in vivo. We thus demonstrate here th
at, while T beta RI is crucial for the function of TGF-beta during vascular
development and can not be compensated for by the activin receptor-like ki
nase-1 (ALK-1), functional hematopoiesis and development of hematopoietic p
rogenitors is not dependent on TGF-beta signaling via T beta RI.